Xcout IntelColoplast
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Subscribe to see Coloplast’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Coloplast at a glance
Coloplast is a medical devices company headquartered in Humlebæk, Denmark. It is publicly listed (CBHD) with a market capitalisation of $14.6B.
Coloplast competitors
A few of Coloplast's closest competitors — see the full list of competitors and alternatives →
Convatec Group plc, is a medical products and technologies company based in London, England, offering products and services in the areas of advanced wound care, ostomy care, continence care and infusion care. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Hollister Incorporated is an independent, employee-owned company headquartered in Libertyville, Illinois. The company develops, manufactures, and markets healthcare products worldwide for ostomy, continence, wound, and critical care markets.
Covalon Technologies Ltd., a Canadian company based in Mississauga, innovates, develops, manufactures, and commercializes medical technologies and products globally. Its operations span major international markets, including North America, Europe, the Middle East, Asia, and Latin America, with licensing agreements in place. The company leverages three distinct proprietary technology platforms. Firstly, its collagen matrix platform underpins a family of products aimed at treating a variety of chronic and infected wounds, such as diabetic, pressure, and venous ulcers, as well as donor and graft sites, traumatic injuries healing by secondary intention, dehisced surgical wounds, and first- and second-degree burns. Secondly, an antimicrobial silicone adhesive platform is incorporated into pre- and post-surgical and vascular access products; these are specifically engineered to provide broad-spectrum antimicrobial protection by eliminating bacteria or yeast on contact. Thirdly, a unique medical coating platform employs a proprietary photo-polymerization process to generate active grafting sites, enabling the initiation and growth of new polymer chains directly on existing medical devices. Covalon's product portfolio, branded under "Covalon," encompasses advanced wound care dressings, surgical and peri-operative solutions, and infection management tools. These offerings reach a diverse clientele, including hospitals, specialized wound and burn centers, acute and long-term care facilities, home health care agencies, and physicians' offices, via a combination of direct sales and extensive third-party distribution networks.
Radiometer is a global medical device company founded in 1935 and headquartered in Copenhagen, Denmark. The company pioneered blood gas testing, introducing the world's first commercially available blood gas solutions.
Cook Medical invents, manufactures, and delivers a portfolio of minimally invasive medical devices for various healthcare specialties, including vascular intervention, critical care, endoscopy, and urology. The company serves healthcare systems, physicians, and medical professionals around the world.
Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items. Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.
Get Coloplast's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Coloplast in Xcout Intel
- The full competitor set, tracking, exports and API access